MSD has agreed to pay up to $610 million to acquire Caraway Therapeutics, a Cambridge, Massachusetts biotech focusing on neurodegenerative disorders and rare diseases. The big pharma, known as ...

Kelun-Biotech has become the second drugmaker to ... Daiichi's was re-filed for EGFR-positive NSCLC only. Outside China, MSD has rights to sac-TMT under the terms of a partnership signed in ...

Drugmaker pauses HPV Gardasil exports as rival Pfizer gets boost from better than expected Covid vaccine and pill sales ...

Danish biotechnology company IO Biotech has finished enrolling subjects in a Phase II trial of its lead therapeutic cancer vaccine candidate, IO102-IO103, in conjunction with MSD's KEYTRUDA ...

SPONSOR PROFILE: About MSD Merck Sharp and Dohme (MSD) is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, MSD discovers, develops, ...

MSD’s submission is based on efficacy and ... GlobalData is the parent company of Pharmaceutical Technology. Welireg comes with a boxed warning about its potential to cause embryo-foetal harm ...